3620 results for «2431»
3620 results
Expanding horizons in coronary calcified lesion management with intravascular lithotripsy
10 Oct 2025 – From AICT-AsiaPCR 2025
This session highlights advancements in managing coronary calcified lesions through intravascular lithotripsy using the Shockwave system. It discusses the unique mechanism of action for different calcium morphologies, reviews the latest clinical data, and addresses complex scenarios including diffuse lesions and challenging nodular or eccentric calcium deposits,...
New insights into mechanical circulatory support: Impella in CGS and protected PCI
10 Oct 2025 – From AICT-AsiaPCR 2025
This session provides in-depth insights into the evolving role of mechanical circulatory support, focusing on the use of Impella devices in cardiogenic shock (CGS) and protected high-risk percutaneous coronary interventions (PCI). Attendees will gain knowledge on patient selection criteria, the impact of the DanGer trial and...
Coronary complications and rescue cases
11 Oct 2025 – From AICT-AsiaPCR 2025
This compelling session addresses complex coronary complications and rescue cases encountered in the cath lab. Through a series of challenging case studies, it highlights critical scenarios such as silent coronary artery threats, procedural nightmares, coronary perforations, and innovative rescue strategies that transform high-risk situations into successful...
Redefining precision and performance in TAVI: advancing clinical outcomes with the Evolut FX+ system
10 Oct 2025 – From AICT-AsiaPCR 2025
Delve into advanced transcatheter aortic valve implantation (TAVI) with the Evolut FX plus system, focusing on its application in patients with small annulus and coronary artery disease (CAD). This session details step-by-step deployment, patient selection, imaging analysis, and highlights the distinctions from the previous Evolut R...
New evidence for treatment of calcified coronary artery disease
20 May 2025 – From EuroPCR 2025
Explore the latest randomized trials and studies advancing the treatment of calcified coronary artery disease. This session covers cutting balloon use, lithotripsy versus conventional preparation, and one-year outcomes comparing rotational atherectomy, lithotripsy, and laser. Also highlighted is the EMPOWER CAD study focusing on women treated with...
Current DCB practice: from lesion preparation to follow-up
21 May 2025 – From EuroPCR 2025
Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
How are we going to treat these sick patients presenting with pulmonary embolism?
21 May 2025 – From EuroPCR 2025
Address the urgent clinical question of how to treat patients presenting with pulmonary embolism across varying risk profiles. This session covers risk stratification and discusses interventional treatment options through detailed case analyses of intermediate and high-risk patients, providing practical guidance for individualized management.
Best companion's case on rotational atherectomy
21 May 2025 – From EuroPCR 2025
Discover expert approaches to rotational atherectomy guided by intravascular ultrasound (IVUS) in treating severely calcified coronary lesions. This session presents complex cases including high-risk LAD tandem lesions and ostial calcification, showcasing the utility of multi-axis rotablation techniques for safe and effective lesion modification.
Overcoming resistant lesions in NSTEMI
21 May 2025 – From EuroPCR 2025
Address the challenges of resistant lesions in NSTEMI with this focused session. Learn from complex cases involving thrombus management using Penumbra systems and Guideliner, as well as strategies to overcome extensive calcification through multiple interventional tools, illustrating a stepwise approach to tackling difficult coronary lesions.
TAVI in challenging anatomical situations
21 May 2025 – From EuroPCR 2025
Delve into the latest advancements in TAVI for challenging anatomical situations. This session features insights from the NORTHOSTAVI registry, transcaval TAVI experiences, early discharge protocols following alternative access, and the application of intravascular lithotripsy to enable safe transfemoral valve replacement.
Transcatheter tricuspid valve replacement in the real world: current data and outcomes
21 May 2025 – From EuroPCR 2025
Explore current real-world data and outcomes of transcatheter tricuspid valve replacement (TTVR). This session reviews UK single-centre experiences, registry data, long-term right ventricular remodeling effects, safety in pacemaker patients, and AI-based CT screening for patient selection.
Enhancing knowledge in diagnosis ANOCA
21 May 2025 – From EuroPCR 2025
Enhance your understanding of the diagnosis of ANOCA through advanced diagnostic techniques. Topics include coronary endothelial function assessment, exercise stress testing for microvascular dysfunction, acetylcholine-induced coronary responses, and the clinical implications of myocardial bridge in provocative testing.
Coils and plugs for coronary intervention
21 May 2025 – From EuroPCR 2025
This session highlights the use of coils and plugs in complex coronary interventions. Through unique case presentations, it covers diagnosis and management of unusual cardiac masses, recurrent fistulas, and rare causes of angina, illustrating innovative device applications in challenging coronary anatomy and post-surgical scenarios.
High-risk plaque assessment with intracoronary imaging
21 May 2025 – From EuroPCR 2025
Explore high-risk plaque assessment using intracoronary imaging modalities such as OCT and AI-driven analysis. This session investigates associations between thin-cap fibroatheroma, local inflammation, and adverse outcomes, highlighting novel biomarkers and imaging techniques that enhance prognostic evaluation and guide personalized coronary artery disease management.
The many faces of TTVR
21 May 2025 – From EuroPCR 2025
Discover the diverse clinical scenarios of transcatheter tricuspid valve replacement (TTVR). This session presents complex cases including acute right ventricular afterload mismatch, combined pulmonary and tricuspid valve interventions in carcinoid heart disease, and challenges in dilated cava anatomy, showcasing the expanding frontiers of TTVR therapy.
How to deal with left main culprit in NSTEMI
21 May 2025 – From EuroPCR 2025
This session offers a cross-geographic exchange on managing left main culprit lesions in NSTEMI patients. Learn different interventional approaches, risk evaluation for periprocedural complications, and diverse PCI management strategies tailored to this complex subgroup.
Paravalvular and defects percutaneous closure
21 May 2025 – From EuroPCR 2025
This session presents percutaneous closure techniques for paravalvular leaks and cardiac defects, highlighting complex cases such as closure in patients with mechanical prostheses, pseudoaneurysms, and post-redo sternotomy challenges. Gain practical knowledge on device selection and procedural strategies for successful leak and defect management.
Challenging STEMI cases: unwanted situations
21 May 2025 – From EuroPCR 2025
Address challenging STEMI cases involving multivessel disease, high thrombus burden, and spontaneous coronary artery dissection. This session provides case-based learning on managing unexpected scenarios, diagnostic approaches, and tailored treatment strategies in complex STEMI presentations.
Improving outcomes of NSTEMI patients
21 May 2025 – From EuroPCR 2025
Review contemporary evidence on improving outcomes for NSTEMI patients. Topics include the effects of evolocumab on stent coverage, impact of left ventricular function with kidney disease, GRACE score-based outcomes, PCI timing, and early initiation of Tafolecimab.
